PNC Financial Services Group
PDLI

PNC Financial Services Group’s PDL BioPharma, Inc. PDLI Stock Holding History

PNC Financial Services Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-297
Closed – – 4186
2020
Q3 		$0 Buy
297
+47
+19% +$150 ﹤0.01% 4173
2020
Q2 		$0 Buy
+250
New +$791 ﹤0.01% 4183
2020
Q1 		– Sell
-801
Closed -$3K – 4214
2019
Q4 		$3K Buy
+801
New +$2.33K ﹤0.01% 3760
2019
Q3 		– Sell
-1,500
Closed -$5K – 4250
2019
Q2 		$5K Sell
1,500
-628
-30% -$2.04K ﹤0.01% 3761
2019
Q1 		$8K Hold
2,128
– – ﹤0.01% 3661
2018
Q4 		$6K Hold
2,128
– – ﹤0.01% 3702
2018
Q3 		$6K Buy
2,128
+128
+6% +$314 ﹤0.01% 3807
2018
Q2 		$5K Hold
2,000
– – ﹤0.01% 3864
2018
Q1 		$6K Sell
2,000
-500
-20% -$1.36K ﹤0.01% 3872
2017
Q4 		$7K Sell
2,500
-1,000
-29% -$3.07K ﹤0.01% 3809
2017
Q3 		$12K Sell
3,500
-1,000
-22% -$2.78K ﹤0.01% 3633
2017
Q2 		$10K Hold
4,500
– – ﹤0.01% 3604
2017
Q1 		$10K Hold
4,500
– – ﹤0.01% 3561
2016
Q4 		$9K Sell
4,500
-200
-4% -$558 ﹤0.01% 3536
2016
Q3 		$15K Sell
4,700
-5,091
-52% -$16.2K ﹤0.01% 3363
2016
Q2 		$29K Sell
9,791
-162
-2% -$540 ﹤0.01% 3100
2016
Q1 		$33K Buy
9,953
+1,839
+23% +$5.73K ﹤0.01% 3029
2015
Q4 		$29K Sell
8,114
-5,279
-39% -$22.1K ﹤0.01% 3119
2015
Q3 		$68K Sell
13,393
-68,516
-84% -$393K ﹤0.01% 2734
2015
Q2 		$527K Sell
81,909
-658
-0.8% -$4.41K ﹤0.01% 1615
2015
Q1 		$581K Buy
82,567
+16,425
+25% +$119K ﹤0.01% 1548
2014
Q4 		$510K Sell
66,142
-13,064
-16% -$103K ﹤0.01% 1546
2014
Q3 		$593K Buy
79,206
+44,713
+130% +$415K ﹤0.01% 1378
2014
Q2 		$334K Buy
34,493
+24,773
+255% +$221K ﹤0.01% 1641
2014
Q1 		$81K Buy
9,720
+4,870
+100% +$41.7K ﹤0.01% 2307
2013
Q4 		$41K Sell
4,850
-1,594
-25% -$13.4K ﹤0.01% 2564
2013
Q3 		$51K Buy
6,444
+850
+15% +$6.83K ﹤0.01% 2483
2013
Q2 		$42K Buy
+5,594
New +$43.6K ﹤0.01% 2468

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Gabelli Funds
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
Winton Group
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Hancock Whitney
Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

PNC Financial Services Group's PDLI Position: Q4 2020 in Review

PNC Financial Services Group sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 297 shares.

PNC Financial Services Group first reported a position in PDLI in Q2 2013 and held it in 28 quarters. The position peaked at $593K in Q3 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • PNC Financial Services Group reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 297 PDL BioPharma, Inc. shares in Q4 2020.
  • PNC Financial Services Group first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 28 quarters.
  • PNC Financial Services Group's PDL BioPharma, Inc. position peaked at $593K in Q3 2014.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on PNC Financial Services Group's 13F filing for Q4 2020, filed 12 Feb 2021.